Utama › Penyakit Hati › Indiana
Kajian klinikal Penyakit Hati di Indiana
6 kajian untuk Penyakit Hati sedang mencari peserta di lokasi di Indiana.
Bandar di Indiana
Teks kajian rasmi (Bahasa Inggeris)
Study of Resmetirom in Children and Adolescents With MASH
- Riley Hospital for Children at IU Health, Indianapolis
Mengambil pesertaFasa 2
Umur 6 hingga 17 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07763015A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Digestive Research Alliance of Michiana, South Bend
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07288138A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Hammond
- 89bio Clinical Study Site, New Albany
- 89bio Clinical Study Site, South Bend
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Hammond
- 89bio Clinical Study Site, New Albany
- 89bio Clinical Study Site, South Bend
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06419374DILIN - Prospective Study
- Indiana University, Indianapolis
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 2 ke atas · Semua jantina · Dikemas kini 8 Apr 2026 · NCT00345930A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
- Indiana University Division of Gastroenterolgy and Hepatology, Indianapolis
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Okt 2025 · NCT05733832Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.